Fluid and imaging biomarkers for Huntington's disease
- 1 June 2019
- journal article
- research article
- Published by Elsevier in Molecular and Cellular Neuroscience
- Vol. 97, 67-80
Abstract
No abstract availableKeywords
Funding Information
- Welcome Trust (200181/Z/15/Z)
- Medical Research Council
This publication has 151 references indexed in Scilit:
- Striatal Volume Contributes to the Prediction of Onset of Huntington Disease in Incident CasesBiological Psychiatry, 2012
- Antioxidants in Huntington's diseaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2012
- Mutant huntingtin, abnormal mitochondrial dynamics, defective axonal transport of mitochondria, and selective synaptic degeneration in Huntington's diseaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2012
- A tale of two factors: What determines the rate of progression in Huntington's disease? A longitudinal MRI studyMovement Disorders, 2011
- Neurocognitive signs in prodromal Huntington disease.Neuropsychology, 2011
- Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysisThe Lancet Neurology, 2011
- Early atrophy of pallidum and accumbens nucleus in Huntington’s diseaseJournal of Neurology, 2010
- Striatal and white matter predictors of estimated diagnosis for Huntington diseaseBrain Research Bulletin, 2010
- Delayed onset of the diurnal melatonin rise in patients with Huntington’s diseaseJournal of Neurology, 2009
- Biomarkers and surrogate endpoints: Preferred definitions and conceptual frameworkClinical Pharmacology & Therapeutics, 2001